| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 创新药研发生产服务(元) | 1,236,374,906.63 | 1,883,689,679.19 | 1,027,537,535.96 | 2,004,981,793.08 | 1,139,433,010.96 |
| 原料药、中间体(元) | 3,603,269,929.28 | 8,651,388,172.77 | 4,704,422,720.91 | 7,987,061,899.85 | 4,204,414,658.10 |
| 制剂(元) | - | - | 679,555,972.19 | 1,249,222,531.40 | 574,079,137.76 |
| 药品(元) | 583,053,763.86 | 1,255,600,899.17 | - | - | - |
| 其他(元) | - | 165,835,078.05 | - | 198,973,429.45 | - |
| 营业成本(元) | |||||
| 创新药研发生产服务(元) | 691,834,266.25 | 1,110,257,836.30 | 615,605,748.01 | 1,157,075,250.99 | 629,298,288.07 |
| 原料药、中间体(元) | 3,109,793,898.97 | 7,356,549,134.43 | 3,941,420,000.51 | 6,584,450,067.93 | 3,425,916,363.29 |
| 制剂(元) | - | - | 269,812,695.57 | 585,399,391.02 | 284,855,612.40 |
| 药品(元) | 227,212,665.85 | 492,096,231.26 | - | - | - |
| 其他(元) | - | 147,342,987.07 | - | 184,586,757.44 | - |
| 毛利(元) | |||||
| 创新药研发生产服务(元) | 544,540,640.38 | 773,431,842.89 | 411,931,787.95 | 847,906,542.09 | 510,134,722.89 |
| 原料药、中间体(元) | 493,476,030.31 | 1,294,839,038.34 | 763,002,720.40 | 1,402,611,831.92 | 778,498,294.81 |
| 制剂(元) | - | - | 409,743,276.62 | 663,823,140.38 | 289,223,525.36 |
| 药品(元) | 355,841,098.01 | 763,504,667.91 | - | - | - |
| 其他(元) | - | 18,492,090.98 | - | 14,386,672.01 | - |
| 毛利率(%) | |||||
| 创新药研发生产服务(%) | 44.04 | 41.06 | 40.09 | 42.29 | 44.77 |
| 原料药、中间体(%) | 13.70 | 14.97 | 16.22 | 17.56 | 18.52 |
| 制剂(%) | - | - | 60.30 | 53.14 | 50.38 |
| 药品(%) | 61.03 | 60.81 | - | - | - |
| 其他(%) | - | 11.15 | - | 7.23 | - |
| 收入构成(%) | |||||
| 创新药研发生产服务(%) | 22.80 | 15.75 | 16.03 | 17.53 | 19.25 |
| 原料药、中间体(%) | 66.45 | 72.36 | 73.37 | 69.82 | 71.05 |
| 制剂(%) | - | - | 10.60 | 10.92 | 9.70 |
| 药品(%) | 10.75 | 10.50 | - | - | - |
| 其他(%) | - | 1.39 | - | 1.74 | - |
| 毛利构成(%) | |||||
| 创新药研发生产服务(%) | 39.07 | 27.14 | 25.99 | 28.95 | 32.33 |
| 原料药、中间体(%) | 35.40 | 45.43 | 48.15 | 47.89 | 49.34 |
| 制剂(%) | - | - | 25.86 | 22.67 | 18.33 |
| 药品(%) | 25.53 | 26.79 | - | - | - |
| 其他(%) | - | 0.65 | - | 0.49 | - |